English deutsch Impressum
Sitemap Disclaimer
Company Product Investor Relations Newsroom Careers Contact
 

Strategy
Facts
Share
Announcements
 Press Releases
 Ad−hoc−announcement
 Voting Rights
 Directors Dealings
Financial reports
Presentations
Annual General Meeting
Corporate Governance
Dates & Events
Annual Document
IR Service

Voting rights announcements persuant to §21 section 1, §26a and §27a section 1
of the WpHG [the German Securities Trading Act]
(Release of the voting rights announcements persuant to § 26, section 1
of the WpHG [the German Securities Trading Act]

 

31.08.2010 Total Voting Rights
12.08.2010 Merlin Biosciences
12.08.2010 Merlin Biosciences_§21 section. 1a (first reporting)
12.08.2010 WestLB
06.07.2010 UCB_§27a
06.07.2010 dievini_§27a
18.06.2010 APAX
10.06.2010 UCB
09.06.2010 dievini (in German only)
08.01.2010 dievini_§27a (in German only)
31.12.2009 Total Voting Rights
14.12.2009 dievini_SalOppenheim (in German only)
11.12.2009 Sal_Oppenheim (in German only)
29.11.2009 dievini_SalOppenheim (in German only)
15.09.2009 WestLB
18.05.2009 Dietmar Hopp
04.03.2009 UCB
03.03.2009 dievini (in German only)
28.02.2009 Total Voting Rights
16.09.2008 dievini (in German only)
04.01.2008 dievini (in German only)
19.12.2007 dievini (in German only)
18.12.2007

dievini (in German only)
24.11.2006 Hopp_Apax_Merlin (in German only)

Shareholder structure

dievini Hopp BioTech 35.78 %
UCB 18.05 %
TVM Capital funds 5.03 %
Merlin funds 4.63 %
Boards (direct ownership) 1.80 %
Remaining free float 34.71 %

Update: 17 August 2010
© 2006 WILEX AG